Randomized trial evaluates obesity's impact on cancer-related fatigue in breast cancer survivors, suggesting essential interventions.
Purpose To evaluate the associations of obesity and cancer-related fatigue (CRF) among breast cancer survivors, and the impact of their co-occurrence on physical function.Methods In a nationwide randomized clinical trial, we assessed body mass index (BMI; kg/m2), CRF via the Brief Fatigue Inventory (BFI), and physical function via hand grip dynamometry (muscular) and 6-minute walk test (cardiorespiratory) among breast cancer survivors at baseline.Results Among 456 participants with a breast cancer diagnosis (stage I–IIIC, mean age 55.9 years, 23.5 months post first-treatment, 86% white), 43.9% have obesity (BMI ≥ 30 kg/m2), and 32.7% have overweight (BMI 25–29.9 kg/m2). Compared to those with a normal weight, survivors with obesity are more than twice as likely to experience moderate-severe CRF (BFI total score ≥ 4; OR [95%CI] = 2.21 [1.35–3.63]). Survivors with co-occurring overweight/obesity and moderate-severe CRF have significantly worse cardiorespiratory function than those with either condition alone.Discussion Overweight/obesity and CRF are highly prevalent among breast cancer survivors. Survivors with obesity experience worse CRF compared to those with normal weight. Survivors with co-occurring overweight/obesity and severe CRF experience worse cardiorespiratory function, and this persists post-diagnosis. Given the long-term detrimental impact of these conditions on QOL and survival, these findings underscore the need for targeted interventions.
No takes yet. Share an insight, caveat, or question.
Mattick et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: